Apogee Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $2.3M | 61k | 37.36 |
| 2024-12-31 | $2.5M | 56k | 45.30 |
| 2024-09-30 | $1.7M | 28k | 58.74 |
| 2024-06-30 | $713k | 18k | 39.35 |
| 2024-03-31 | $6.2M | 93k | 66.45 |
| 2023-12-31 | $105k | 3.8k | 27.94 |